Gefapixant for Chronic Cough-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Gefapixant for Chronic Cough

Published:2024-02-13 Issue:6 Volume:331 Page:529
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Turner Richard D.¹,Smith Jaclyn A.²,Birring Surinder S.³

Affiliation:

1. School of Medicine and Dentistry, Griffith University, Southport, Queensland, Australia

2. Division of Infection, Immunity and Respiratory Medicine, University of Manchester, Manchester, England

3. Centre for Human and Applied Physiological Sciences, King’s College London, London, England

Publisher

American Medical Association (AMA)

Link

https://jamanetwork.com/journals/jama/articlepdf/2814892/jama_turner_2024_le_230153_1707775803.65701.pdf

Reference4 articles.

1. Discrepancies between meta-analyses and subsequent large randomized, controlled trials.;LeLorier;N Engl J Med,1997

2. Efficacy and tolerability of gefapixant for treatment of refractory or unexplained chronic cough: a systematic review and dose-response meta-analysis.;Kum;JAMA,2023

3. Clinical formulation bridging of gefapixant, a P2X3-receptor antagonist, for the treatment of chronic cough.;Gupta;Clin Pharmacol Drug Dev,2022

4. Efficacy and safety of gefapixant, a P2X3 receptor antagonist, in refractory chronic cough and unexplained chronic cough (COUGH-1 and COUGH-2): results from two double-blind, randomised, parallel-group, placebo-controlled, phase 3 trials.;McGarvey;Lancet,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP